Literature DB >> 34001428

Self-testing with antigen tests as a method for reduction SARS-CoV-2.

Frank W Peacock1, Tomasz Dzieciatkowski2, Francesco Chirico3, Lukasz Szarpak4.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 34001428      PMCID: PMC8099538          DOI: 10.1016/j.ajem.2021.05.010

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


× No keyword cloud information.
To the Editor, In the COVID-19 pandemic, the provision of adequate health care to patients is fundamental to keep mortality low. Medical stuff, in particular emergency medical service personnel, who represent the first line of the fight against COVID-19 [1]. It is in the pre-hospital setting that each patient should be treated as a potentially infectious patient, and it particularly exposed medical stuff working on front line to the risk of SARS-CoV-2 infection [2]. In a systematic review, Bandyopadhyay et al. examine data of 152,888 HCWs infections show mortality at 0.9% level [3]. However, they also calculate mortality at level 37.2 death per 100 infections for HCWs over 70 years. Rivett et al. study 3% of tested in the HCW asymptomatic screening group were SARS-CoV-2 positive [4]. Accurate testing allows identification of people who might need treatment, or who need to isolate themselves to prevent the spread of infection. In connection with the above, screening of emergency medicine stuff with minimal or no symptoms is approach which will be critical for protecting patients and all medical staff. The increasing availability of antigen tests allows their use in hospital, pre-hospital and home settings. The specificity of immunological tests detecting AG antigens prove the current infection with SARS-CoV-2 virus [5]. Currently, antigen tests have been recognized as equivalent to genetic tests performed by RT-qPCR. Some tests require a nasal specimen that can be collected using an anterior nasal swab or a nasal mid-turbinate swab, other require a saliva specimen. The next step after collecting the biological material is mixing it with the buffer fluid. Then, after applying a few drops (depending on the test manufacturer) of the got sample to the test, the gold-antibody conjugate is hydrated and the COVID-19 antigen, if present in the sample, will interact with the gold-conjugated antibodies. The antigen-antibody-gold complex will migrate towards the test window as far as the Test Zone, where it will be captured by the immobilized antibodies, creating a visible pink line (Assay Band) showing a positive result. The advantage of rapid antigen tests, based on lateral flow immunochromatographic assays (LFIA), is short-term of detection, while their disadvantages are lower sensitivity than RT-qPCR and the possibility of obtaining a negative result in a person infected with SARS-CoV-2. The studies published at the beginning of the COVID-19 pandemic indicated that the sensitivity of first generation of rapid tests detecting SARS-CoV-2 antigens in the tested sample ranged from 34% to 80% [6]. Thanks to the possibility of obtaining the result in just a few or several minutes, the second generation of antigen test a quick and proper diagnostic tool, and nowadays its effectiveness is as high as sensitivity ≥90% and specificity ≥97%. An example of such a test is the COVID-19 antigen rapid test (SG Diagnostics, Singapore), the instructions for results interpretation was presented in Fig. 1 .
Fig. 1

How to read the test results.

How to read the test results. The antigen tests also gained recognition for assessing patients already in the pre-hospital stage. An example of the use of COVID-19 antigen tests at the prehospital care stage can be Emergency Medical Services in Warsaw (Poland), where every patient suspected of COVID-19 or having contact with the patient is subject to quick diagnosis using the test, thanks to which paramedics know whether it should be transported to a hospital dedicated to COVID-19 patients or a normal hospital [7]. Rapid antigen tests should be used to diagnose SARS-CoV-2 infections mostly in symptomatic patients during the first 5-7 days after symptom onset. Symptomatic individuals with a positive SARS-CoV-2 antigen test result should be treated as infected. The negative result of this test requires verification if the clinical picture or significant epidemiological premises suggest COVID-19 infection, because a negative result of the antigen test does not exclude infection with the virus. In summary, screening of emergency medicine stuff and EMS patients with minimal or no symptoms is an approach which will be critical for protecting patients and all medical staff.
  5 in total

Review 1.  COVID-19 challenge for modern medicine.

Authors:  Tomasz Dzieciatkowski; Lukasz Szarpak; Krzysztof J Filipiak; Milosz Jaguszewski; Jerzy R Ladny; Jacek Smereka
Journal:  Cardiol J       Date:  2020-04-14       Impact factor: 2.737

2.  Infection and mortality of healthcare workers worldwide from COVID-19: a systematic review.

Authors:  Soham Bandyopadhyay; Ronnie E Baticulon; Murtaza Kadhum; Muath Alser; Daniel K Ojuka; Yara Badereddin; Archith Kamath; Sai Arathi Parepalli; Grace Brown; Sara Iharchane; Sofia Gandino; Zara Markovic-Obiago; Samuel Scott; Emery Manirambona; Asif Machhada; Aditi Aggarwal; Lydia Benazaize; Mina Ibrahim; David Kim; Isabel Tol; Elliott H Taylor; Alexandra Knighton; Dorothy Bbaale; Duha Jasim; Heba Alghoul; Henna Reddy; Hibatullah Abuelgasim; Kirandeep Saini; Alicia Sigler; Leenah Abuelgasim; Mario Moran-Romero; Mary Kumarendran; Najlaa Abu Jamie; Omaima Ali; Raghav Sudarshan; Riley Dean; Rumi Kissyova; Sonam Kelzang; Sophie Roche; Tazin Ahsan; Yethrib Mohamed; Andile Maqhawe Dube; Grace Paida Gwini; Rashidah Gwokyala; Robin Brown; Mohammad Rabiul Karim Khan Papon; Zoe Li; Salvador Sun Ruzats; Somy Charuvila; Noel Peter; Khalil Khalidy; Nkosikhona Moyo; Osaid Alser; Arielis Solano; Eduardo Robles-Perez; Aiman Tariq; Mariam Gaddah; Spyros Kolovos; Faith C Muchemwa; Abdullah Saleh; Amanda Gosman; Rafael Pinedo-Villanueva; Anant Jani; Roba Khundkar
Journal:  BMJ Glob Health       Date:  2020-12

3.  COVID-19 testing for providers: Leading by example.

Authors:  David Greenky; Susan Wiltrakis
Journal:  Am J Emerg Med       Date:  2021-01-11       Impact factor: 2.469

4.  Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmission.

Authors:  Lucy Rivett; Sushmita Sridhar; Dominic Sparkes; Matthew Routledge; Nick K Jones; Ian G Goodfellow; Stephen Baker; Michael P Weekes; Sally Forrest; Jamie Young; Joana Pereira-Dias; William L Hamilton; Mark Ferris; M Estee Torok; Luke Meredith; Martin D Curran; Stewart Fuller; Afzal Chaudhry; Ashley Shaw; Richard J Samworth; John R Bradley; Gordon Dougan; Kenneth Gc Smith; Paul J Lehner; Nicholas J Matheson; Giles Wright
Journal:  Elife       Date:  2020-05-11       Impact factor: 8.140

5.  Comparison of different serological assays for SARS-CoV-2 in real life.

Authors:  Etienne Brochot; Baptiste Demey; Lynda Handala; Catherine François; Gilles Duverlie; Sandrine Castelain
Journal:  J Clin Virol       Date:  2020-08-02       Impact factor: 3.168

  5 in total
  5 in total

1.  Compliance with safety measures and risk of COVID-19 transmission among healthcare workers.

Authors:  Nawaf J Shatnawi; Zaid Mesmar; Gaith A Al-Omari; Wesam Al-Sheyab; Nabil A AlZoubi; Mohammed Al-Ghazo; Shadi Hamouri; Ibraheem Al-Faori; Ali Bani-Essa; Ismail Matalka; Yousef S Khader; Anwar Batieha
Journal:  Future Sci OA       Date:  2021-10-29

2.  Clinical epidemiological applicability of real-time polymerase chain reaction for COVID-19.

Authors:  Geehyuk Kim; Jun-Kyu Kang; Jungho Kim; Jiyoung Lee; Jin Gwack
Journal:  Osong Public Health Res Perspect       Date:  2022-07-27

3.  Coping with the third wave of the COVID-19 pandemic in Africa: implications for an improved outbreak response.

Authors:  Olayinka Stephen Ilesanmi; Francesco Chirico; Aanuoluwapo Adeyimika Afolabi; Gabriella Nucera
Journal:  Future Virol       Date:  2021-01-17       Impact factor: 1.831

4.  Identifying asymptomatic cases during the mass COVID-19 vaccination campaign: insights and implications for policy makers.

Authors:  Francesco Chirico; Gabriella Nucera; Olayinka Ilesanmi; Aanuoluwapo Afolabi; Michal Pruc; Lukasz Szarpak
Journal:  Future Virol       Date:  2021-12-15       Impact factor: 1.831

5.  Evaluation of the Practicability of Biosynex Antigen Self-Test COVID-19 AG+ for the Detection of SARS-CoV-2 Nucleocapsid Protein from Self-Collected Nasal Mid-Turbinate Secretions in the General Public in France.

Authors:  Serge Tonen-Wolyec; Raphaël Dupont; Natalio Awaida; Salomon Batina-Agasa; Marie-Pierre Hayette; Laurent Bélec
Journal:  Diagnostics (Basel)       Date:  2021-11-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.